TP53 family members and human cancers (Q35078717)

6 August 2017

1 reference

title

TP53 family members and human cancers (English)

1 reference

6 August 2017

Jean Bénard

1

1 reference

PubMed ID

12619104

6 August 2017

Setha Douc-Rasy

series ordinal

2

1 reference

PubMed ID

12619104

6 August 2017

Jean-Charles Ahomadegbe

series ordinal

3

1 reference

6 August 2017

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

21

1 reference

6 August 2017

182-191

1 reference

6 August 2017

3

1 reference

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers

6 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Mdm2 binds p73 alpha without targeting degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Two new p73 splice variants, gamma and delta, with different transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Induction of neuronal differentiation by p73 in a neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

AIS is an oncogene amplified in squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p63 is a p53 homologue required for limb and epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p73 is over-expressed in vulval cancer principally as the Delta 2 isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

An anti-apoptotic role for the p53 family member, p73, during developmental neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

A novel protein with strong homology to the tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

c-Abl: activation and nuclear targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Role of p73 in malignancy: tumor suppressor or oncogene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

1p36: every subband a suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

On the shoulders of giants: p63, p73 and the rise of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

MDM2 and MDMX can interact differently with ARF and members of the p53 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

Genomic and allelic expression status of thep73 gene in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

Role of methylation in the control of DeltaNp73 expression in neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

Wild type p73 overexpression and high-grade malignancy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

DeltaN-p73alpha accumulates in human neuroblastic tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

https://api.crossref.org/works/10.1002%2FHUMU.10172

1 reference

7 January 2021

Expression of p73 and Reelin in the developing human cortex.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

DeltaNp63 induces beta-catenin nuclear accumulation and signaling

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

p53 Family members p63 and p73 are SAM domain-containing proteins

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

MDM2 suppresses p73 function without promoting p73 degradation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10172

7 January 2021

Identifiers

DOI

10.1002/HUMU.10172

1 reference

6 August 2017

1 reference

PubMed ID

12619104